Coronavirus Update: Inside Moderna's Deal With The US
Plus: Generex Forges Vaccine Partnership
Company receives a base payment of $1.225bn for the manufacturing and delivery of the first 100 million disease, plus a bonus if mRNA-1273 reaches the market quickly.
You may also be interested in...
Will Moderna-NIH Patent Dispute Change Government-Industry Collaborations?
US government may add provisions to future agreements to ensure its inventorship rights and make terms more favorable to the public. Lawyers say it will be difficult for Moderna to exclude NIH as co-inventor. But NIH lost a similar battle over AZT patents.
Can Moderna Meet Its COVID Vaccine Expectations?
Analysts have cut forecasts for Moderna’s COVID-19 vaccine – but there is still much to play for as key readouts approach.
Moderna Takes Middle Ground On Pricing With 100 Million Dose US Agreement
Pricing set somewhere down the middle as Moderna reaches deal with US government on initial supplies of its mRNA coronavirus vaccine.